The neuropeptide urotensin II (UII) is expressed in motoneurons of the brainstem and spinal cord in adults. Here, the expression pattern of the UII gene was studied in the developing rat spinal cord. UII mRNA was detected by reverse-transcription-polymerase chain reaction (RT-PCR) as early as E10. From E14 to E21, in situ hybridization revealed intense expression of the UII gene speci®cally in sacral motoneurons, while only faint expression was detected at cervical and thoracic levels. After birth (P0, P4), the expression of UII mRNA increased in motoneurons at all rostrocaudal levels. Thus, UII is the ®rst gene reported to show expression limited to the sacral pool of motoneurons, which are known to have particular properties in terms of targets and programmed cell death. q
Results
Urotensin II (UII) is a cyclic neuropeptide originally isolated from the caudal neurosecretory system of teleost ®sh (Pearson et al., 1980) , but it is only recently that the existence of a UII gene was demonstrated in amphibian (Conlon et al., 1992) and mammals (Coulouarn et al., 1998 (Coulouarn et al., , 1999 Mori et al., 1999) . Interestingly, in all terrestrial vertebrates investigated to date, UII mRNA is predominantly expressed in cranial and spinal motoneurons (Coulouarn et al., 1998 (Coulouarn et al., , 1999 Ames et al., 1999) .
Analysis of UII gene expression pattern during rat development by reverse-transcription-polymerase chain reaction (RT-PCR) revealed that UII mRNA is expressed from E10 to adult (Fig. 1) . At E14, E17 and E21 (E21 is not shown), in situ hybridization (ISH) performed on sagittal sections showed that the UII gene was exclusively expressed in the spinal cord, the strongest signal being observed at the caudal level (Fig. 2) . The high concentration of UII mRNA in the sacral region was con®rmed by ISH on whole-mount preparations of dissected spinal cords from E14.5 to E18.5 rats; only much lower signals were detected in thoracic and cervical regions (Fig. 3) . Sacral UII-positive cells were also labeled by probes to Islet-1, a LIM transcription factor expressed by all embryonic motoneurons soon after they leave the cell cycle (not shown; see Yamamoto and Henderson, 1999) . Comparison of the staining patterns for Islet-1 and UII suggested that the majority of sacral motoneurons express UII at this stage.
Although several neuropeptides are present in motoneurons during development, the expression of all these neuropeptides, with the exception of CGRP, vanishes around birth (Marti et al., 1987; Arvidsson et al., 1993) . Thus, UII is the second neuropeptide described so far in motoneurons of both fetuses and adult (Fig. 1) . Comparison of cytoautoradiographic signals between stages E21 (not shown) and P0/ P4 revealed that the levels of UII mRNA increased in the spinal cord after birth at all rostrocaudal levels (Fig. 4) . Depending on the level considered, several populations of positives motoneurons were distinguished, occupying a ventromedial (Fig. 4E±H ,M±R,T) or ventrolateral ( (00)00548-7 www.elsevier.com/locate/modo (Tsuchida et al., 1994) . The presence of UII mRNA-containing neurons in a more dorsal position ( Fig. 4N ) is interesting because this region contains visceral motoneurons controlling heart rate, and UII has been shown to induce profound cardiovascular effects when injected into anaesthetized monkeys (Ames et al., 1999) .
UII mRNA is expressed in the rat embryo at E10, a time when motoneurons undergo their terminal mitosis and precedes motoneuronal differentiation (Phelps et al., 1988 (Phelps et al., , 1991 Chen and Chiu, 1992) . Unfortunately, the sensitivity of ISH and PCR is not of the same order, and we could not characterize the population of cells that contains the messenger. As UII gene is expressed in motoneurons at all other embryonic stages examined, in neonate and in adult (Coulouarn et al., 1999) , it is tempting to associate the onset of UII mRNA expression with motoneuron differentiation. As in nearly all neuronal populations, target contact by motoneurons is rapidly followed by a wave of programmed cell death (PCD) that proceeds gradually from the rostral to the caudal region (Yamamoto and Henderson, 1999) suggesting that UII could be involved in either survival or death of motoneurons at sacral levels.
The columns of motoneurons in the sacral regions of the spinal cord have in general been considered to be the caudal extremities of the medial motor columns (MMC; Tsuchida et al., 1994) . The discovery that UII is a speci®c marker for this population during embryogenesis raises the possibility that sacral motoneurons are subject to speci®c developmental controls. This would ®t well with other atypical aspects of their cell death and/or survival. For instance, whereas naturally-occurring PCD of other motoneuron populations leads on average to loss of ca. 50% of the neurons initially generated, this ®gure is closer to 90% for sacral motoneurons (Oppenheim et al., 1989; Yamamoto and Henderson, 1999) . Moreover, the sacral motoneurons include Onuf's nucleus, which innervates the anal sphincter and is particularly resistant to cell death following poliovirus infection (Kojima et al., 1989) , and in patients with amyotrophic lateral sclerosis (Mannen et al., 1982; Gibson et al., 1988; Carvalho et al., 1995) . In accordance with this, these motoneurons show different patterns of expression of molecules potentially associated with cell death or function (Koliatsos et al., 1994; Nacimiento et al., 1993; Brown et al., 1995) . Further understanding of the development of sacral motoneurons is therefore of both developmental and pathological signi®cance.
Methods

RT-PCR ampli®cation
Total RNAs (1 mg) were isolated from whole embryos (E10, E14) or from dissected spinal cords (E17, E21, PO, P4 Fig. 1 . RT-PCR ampli®cation of UII precursor from RNA puri®ed from whole embryos (E10, E14) or dissected spinal cords (E17, E21, P0, P4, adult). The PCR products were stained with BET (top lane) and hybridized with a rat 32 P-labeled internal oligonucleotide probe (second row; the E10 gel lane was exposed longer). Ethidium bromide staining of GAPDH products showed that similar amounts of mRNA were reverse-transcribed. The primers were chosen in different putative exons (deduced from the human gene organization) of the rat UII gene, ensuring that they did not amplify any genomic product (not shown). Fig. 2 . ISH localization of UII precursor mRNA (arrowheads) on sagittal sections of rat embryo at E14 and E17 using a 35 S-labeled riboprobe. and adult) using the Tri reagent (Sigma). PCR was performed for 30 cycles with forward (5 H -AGCTTC-CAGTGCTTGAGGAA-3 H ) and reverse (5 H -GAATCTT-GCCCAGTGAGAGC-3 H ) primers designed from rat prepro-UII cDNA.
ISH on tissue sections
Tissue sections were prehybridized as previously described (Coulouarn et al., 1999) . Hybridization was performed overnight at 558C with antisense and sense 35 Slabeled rat UII riboprobes, corresponding to the whole coding region of UII mRNA (500 nt), prepared by in vitro transcription of PCR products obtained with prepro-UII speci®c sens (5 H -GGAGCAGACACCCAGCCAGA-3 H ) and antisens (5 H -TCATAGTGGAGAACGGGGCG-3 H ) primers 5
H -extended with SP6 and T7 ARN polymerase promoters, respectively. Fig. 4 . ISH localization of UII precursor mRNA on transverse sections of the spinal cord from P0 (top panel) and P4 (bottom panel) rats using a 35 S-labeled UII riboprobe. The sections were counterstained with eosin and hematoxylin to identify neuroanatomical structures. Both bright ®eld photomicrographs (A±D,I± L,Q±T) and dark®eld photomicrographs (E±H,M±P) are shown; silver grains appear dark in (A±D,I±L,Q±T). Q±T, Higher magni®cation showing UII mRNAcontaining motoneurons (arrowheads) at cervical (Q), thoracic (R), lumbar (S) and sacral (T) levels, from P0 (Q,S) and P4 (R,T) rats. Emulsions were exposed for 2 months.
Whole-mount ISH
Whole-mount ISH was performed on E14.5±E18.5 paraformaldehyde (4%)-®xed rat spinal cords as described by Arce et al. (1999) . Brie¯y, hybridization was performed overnight at 708C using DIG-labeled antisense rat UII riboprobes diluted in 50% formamide-containing buffer. Speci®c labelling was visualized by incubation with anti-DIG antibody conjugated to alkaline phosphatase followed by NBT/ BCIP treatment.
